Wyatt, Linda S; Belyakov, Igor M; Earl, Patricia L et al. (2008) Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVA. Virology 372:260-72
|
Wyatt, Linda S; Earl, Patricia L; Vogt, Jennifer et al. (2008) Correlation of immunogenicities and in vitro expression levels of recombinant modified vaccinia virus Ankara HIV vaccines. Vaccine 26:486-93
|
Earl, Patricia L; Americo, Jeffrey L; Wyatt, Linda S et al. (2007) Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate. Virology 366:84-97
|
Zerlin, M; Julius, M A; Cerni, C et al. (1987) Elevated expression of an exogenous c-myc gene is insufficient for transformation and tumorigenic conversion of established fibroblasts. Oncogene 1:19-27
|
Nepveu, A; Marcu, K B (1986) Intragenic pausing and anti-sense transcription within the murine c-myc locus. EMBO J 5:2859-65
|
Remmers, E F; Yang, J Q; Marcu, K B (1986) A negative transcriptional control element located upstream of the murine c-myc gene. EMBO J 5:899-904
|
Fahrlander, P D; Piechaczyk, M; Marcu, K B (1985) Chromatin structure of the murine c-myc locus: implications for the regulation of normal and chromosomally translocated genes. EMBO J 4:3195-202
|
Nepveu, A; Fahrlander, P D; Yang, J Q et al. (1985) Amplification and altered expression of the c-myc oncogene in A-MuLV-transformed fibroblasts. Nature 317:440-3
|
Greenberg, R; Hawley, R; Marcu, K B (1985) Acquisition of an intracisternal A-particle element by a translocated c-myc gene in a murine plasma cell tumor. Mol Cell Biol 5:3625-8
|